Matthew Ferguson - 31 Jul 2024 Form 4 Insider Report for ELUTIA INC. (ELUT)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Jeffrey Hamet, Attorney-in-Fact for Matthew Ferguson
Issuer symbol
ELUT
Transactions as of
31 Jul 2024
Net transactions value
+$150,002
Form type
4
Filing time
31 Jul 2024, 17:00:05 UTC
Previous filing
12 Jun 2024
Next filing
13 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELUT Class A Common Stock Options Exercise $150,002 +105,080 +69% $1.43 257,823 31 Jul 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELUT Warrants (rights to buy) Options Exercise $0 -105,080 -100% $0.000000* 0 31 Jul 2024 Class A Common Stock 105,080 $1.43 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction represents shares of the Issuer's Class A Common Stock received from the exercise of the warrant dated September 21, 2023.
F2 The warrant expires upon the earlier of (a) 30 trading days after the clearance by the U.S. Food & Drug Administration of the issuer's CanGarooRM antibiotic-eluting biologic envelope or (b) September 21, 2028.